AzTrials
AzTrials

Homes for the AgedIntel@Med-PocNCT04679181

Acceptability Assessment of an "Organization of Care Integrating Artificial Intelligence and a Solution of Telemedicine" on Care of the Nursing Home Residents Located in a Medical Desert: Pilot Study INTEL@MED-POC

A study testing Telemedecine in people with Homes for the Aged, run by University Hospital, Limoges at 6 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

While depend elderly people needs are important in Nursing Home, the medical resources are weak from both inside and outside residences located in a medical desert. The goal of this project is to measure the acceptability of Artificial Intelligence and Telemedicine in Nursing Home located in medical desert for… Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Homes for the Aged
What is being tested?
Telemedecine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
137 participants
Where
6 sitesFrance
Study dates
15 Dec 2020to 25 Mar 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Patient older than 65 years old.
  • Patient living in Nursing Home located in medical desert.
  • Patient presenting symptoms involved medical doctor call.
  • Patient or legal representative having signed consent form
  • Patient covered by social security

Who cannot join

  • End of life patient.
  • Chronic aphasic patient.

Trial locations and contacts

6 sites in 1 country.

6 sites in 1 country

France6 sites
  • EHPAD Le Bois Joli

    Auzances, 23700

  • EHPAD Le Chant des Rivières

    Chambon-sur-Voueize, 23170

  • EHPAD La Porte d'Aquitaine

    La Roche-Chalais, 24490

  • Ehpad Le Chavanon

    Merlines, 19340

  • EHPAD Ernest Coulaud

    Peyrelevade, 19290

  • EHPAD J et M Colaud

    Saint-Privat, 19220

Other trials in France

About this study

While depend elderly people needs are important in Nursing Home, the medical resources are weak from both inside and outside residences located in a medical desert. The goal of this project is to measure the acceptability of Artificial Intelligence and Telemedicine in Nursing Home located in medical desert for patients, nurses, and medical doctor

Read the detailed description

The ageing of the population comes along with the problematic of chronic pathologies and dependence, with sometimes serious consequences resulting in an admission in Nursing Home. While the low require a medical doctor in each Nursing Home, one third of the Nursing Home does not have. Some Nursing Homes can be in a tricky situation with no medical doctor coordinator and the difficulty of access to a medical doctor who covered a wide territory. In this context, the emergence of Artificial Intelligence coupled with Telemedicine is a new opportunity to find solution in healthcare organization and to develop advanced geriatric medical practice in medical desert territory. The goal of this study is to quantify and characterize the acceptability of Artificial Intelligence and Telemedicine in Nursing Home located in medical desert for patients, nurses, and medical doctor.

All the patients were examined by a nurse. The symptoms filled by the nurse in the Artificial Intelligence/Telemedicine device are sent and then analyzed by a distant medical doctor to purpose a care. The nurse also solicited the attending medical doctor as usual care.

The recommendations of the both medical doctors could be (i) Vital emergency, (ii) non-vital emergency necessitate medication or hospitalization, and (iii) non-emergency with medical appointment.

Being tested
Telemedecine
Keywords
aged, telemedicine, artificial intelligence

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TelemedecineOther

    telemedical consultation

Study groups in NCT04679181
Study groupRoleWhat they receive
Active armExperimentaluse of telemedicine
Receives: Other: Telemedecine

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Acceptability for nurse to use Artificial Intelligence / Telemedecine device analyzed by distant medical doctor

    Proportion of the Artificial Intelligence / Telemedecine utilization by the nurse vs medical doctor as usual care

    Measured: 13 months

  2. Number of non-programmed hospitalization for both distant medical doctor and usual care recommendations

    Comparison of non programmed hospitalization in both distant medical doctor analysis and medical doctor as usual care

    Measured: 13 months

  3. delay to obtain the medical expertise

    Comparison of time to obtain the medical expertise for distant medical doctor and usual care recommandations

    Measured: 13 months

Secondary outcomes (1)
  1. sensitivity and specificity of diagnostic

    Calculation of sensitivity and specificity of diagnostic for acute disease and emergency for both distant medical doctor and usual care recommendations

    Measured: 13 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Dec 2020
  2. Study start15 Dec 2020
  3. Primary completion25 Apr 2023
  4. Study completion25 Mar 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
137 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04679181
Sponsor's protocol ID
87RI18-0018/Intel@Med-Poc
Acronym
Intel@Med-Poc
Status last verified
Jun 2026
First submitted
3 Dec 2020
Last updated
26 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Telemedecine in people with Homes for the Aged, run by University Hospital, Limoges at 6 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Acceptability for nurse to use Artificial Intelligence / Telemedecine device analyzed by distant medical doctor (time frame: 13 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in